Anixa Biosciences, Inc. (ANIX) vs Immunic, Inc. (IMUX)
A side-by-side comparison of Anixa Biosciences, Inc. and Immunic, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ANIX
Anixa Biosciences, Inc.
$3.07HealthcareDelayed quote: Oct 6, 2026, 1:49 PM EDT
IMUX
Immunic, Inc.
$7.85HealthcareDelayed quote: Oct 6, 2026, 1:49 PM EDT
Total return — ANIX vs IMUX
growth of $100 · dividends reinvested · last 10yANIX -39.3% (-4.9%/yr)IMUX -99.7% (-43.5%/yr)ANIX compounded faster over this window
Log scale — wide-divergence pair
ANIX IMUX
ANIX vs IMUX: by the numbers
- •IMUX is the larger company ($107M vs $104M market cap).
Metrics side by side
Valuation
| Metric | ANIX | IMUX |
|---|---|---|
| P/B ratio | 7.22 | 0.84 |
Profitability
| Metric | ANIX | IMUX |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -72.02% | -87.45% |
| ROIC | -82.35% | -92.16% |
Growth (annualized)
| Metric | ANIX | IMUX |
|---|---|---|
| Total return CAGR (5Y) | -8.26% | -35.70% |
Frequently asked
- How have ANIX and IMUX total returns compared?
- Over the past 10 years, ANIX delivered -4.65% and IMUX delivered -43.80% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.